Actively Recruiting
Effect of Breather in COPD Patients With Intermittent Claudication
Led by Cairo University · Updated on 2024-12-31
60
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.
CONDITIONS
Official Title
Effect of Breather in COPD Patients With Intermittent Claudication
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients aged 55 to 60 years diagnosed with grade I or grade II COPD
- Clinically and medically stable at study entry
- Body mass index (BMI) between 18.5 and 24.9 kg/m2
- History of unilateral exertional leg pain
- Limited walking ability due to leg pain consistent with intermittent claudication (stage II of the Fontaine classification of PAD)
- Ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise
You will not qualify if you...
- Cardiovascular insufficiency
- Recent myocardial infarction
- Heart failure
- Arrhythmia
- Deep vein thrombosis (DVT)
- Intracranial hypertension
- Pneumonia
- Kidney failure
- Bone fractures
- Uncooperative patients
- Cognitive impairment preventing participation in exercises
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Physical Therapy
Dokki, Egypt
Actively Recruiting
Research Team
R
Reem M Farahat, student
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here